A traditional, siloed approach has hampered the development of gene-targeted therapies for rare diseases. The need for a more collaborative approach was discussed at a 3-day virtual meeting hosted in 2021 by the National Institutes of Health,...
A traditional, siloed approach has hampered the development of gene-targeted therapies for rare diseases. The need for a more collaborative approach was discussed at a 3-day virtual meeting hosted in 2021 by the National Institutes of Health,...
A traditional, siloed approach...